A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
Cancer Trials Ireland
Cancer Trials Ireland
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
University of Pittsburgh
NRG Oncology
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Children's Oncology Group
University of Iowa
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center